Leu(10) of alpha-conotoxin PnIB confers potency for neuronal nicotinic responses in bovine chromaffin cells


Autoria(s): Broxton, N; Miranda, L; Gehrmann, J; Down, J; Alewood, P; Livett, B
Data(s)

01/03/2000

Resumo

Two alpha-conotoxins PnIA and PnIB (previously reported as being mollusc specific) which differ in only two amino acid residues (AN versus LS at residues 10 and 11, respectively), show markedly different inhibition of the neuronal nicotinic acetylcholine receptor response in bovine chromaffin cells, a mammalian preparation. Whereas alpha-conotoxin PnIB completely inhibits the nicotine-evoked catecholamine release at 10 mu M, with IC50 = 0.7 mu M, alpha-conotoxin PnIA is some 30-40 times less potent. Two peptide analogues, [A10L]PnIA and [N11S]PnIA were synthesized to investigate the extent to which each residue contributes to activity. [A10L]PnIA (IC50 = 2.0 mu M) completely inhibits catecholamine release at 10 mu M whereas [N11S]PnIA shows Little inhibition. In contrast, none of the peptides inhibit muscle-type nicotinic responses in the rat hemi-diaphragm preparation. We conclude that the enhanced potency of alpha-conotoxin PnIB over alpha-conotoxin PnIA in the neuronal-type nicotinic response is principally determined by the larger, more hydrophobic leucine residue at position 10 in alpha-conotoxin PnIB. (C) 2000 Elsevier Science B.V. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:36262

Idioma(s)

eng

Publicador

Elsevier

Palavras-Chave #Pharmacology & Pharmacy #Conotoxin #Neuronal Nicotinic Receptor #Acetylcholine Receptor #Chromaffin Cell #Nicotinic Receptor Antagonist #Catecholamine #Acetylcholine-receptors #Crystal-structure #Expression #Peptide #Organization #Specificity #Alzheimers #Cloning #Disease #Imi #C1 #030503 Organic Chemical Synthesis #119999 Medical and Health Sciences not elsewhere classified
Tipo

Journal Article